Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03802604 |
| Title | Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer (PROMETEO) |
| Acronym | PROMETEO |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | SOLTI Breast Cancer Research Group |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hospital Universitari Vall d'Hebrón | Barcelona | 08035 | Spain | Details | ||
| Hospital Clínic de Barcelona | Barcelona | 08036 | Spain | Details | ||
| Centro Integral Oncológico Clara Campal | Madrid | 28050 | Spain | Details | ||
| Hospital Clínico universitario de Valencia | Valencia | 46010 | Spain | Details |